We are live on ! Find out more
ELGX

Endologix Inc
ELGX

Delisted

ELGX was delisted on the 15th of July, 2020.

120 hedge funds and large institutions have $701M invested in Endologix Inc in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 37

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

1% more funds holding

Funds holding: 119120 (+1)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

30% less capital invested

Capital invested by funds: $1,000M → $701M (-$299M)

94% less call options, than puts

Call options by funds: $6K | Put options by funds: $96K

Holders
120
Holders Change
+1
Holders Change %
+0.84%
% of All Funds
3.48%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
14
Increased
40
Reduced
37
Closed
13
Calls
$6K
Puts
$96K
Net Calls
-$90K
Net Calls Change
+$2.09M
Name Holding Trade Value Shares
Change
Change in
Stake
JHIU
1
Janus Henderson Investors US
Colorado
$85M +$4.44M +31,882 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$40.3M +$1.75M +12,588 +3%
TCM
3
Tamarack Capital Management
California
$35M +$12.9M +92,500 +39%
EWM
4
Essex Woodlands Management
Texas
$31.6M -$4.18M -30,000 -11%
ACH
5
ArrowMark Colorado Holdings
Colorado
$28.3M +$2.16M +15,505 +6%
DM
6
Deerfield Management
New York
$26.5M +$14.2M +101,960 +69%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$24.8M +$5.14M +36,885 +19%
PCM
8
Palisade Capital Management
New Jersey
$23.3M +$21.3K +153 +0.1%
ClearBridge Investments
9
ClearBridge Investments
New York
$22.3M +$186K +1,337 +0.6%
EAM
10
Eagle Asset Management
Florida
$21.3M -$3.01M -21,603 -10%
Luther King Capital Management (LKCM)
11
Luther King Capital Management (LKCM)
Texas
$20.8M -$497K -3,565 -2%
Goldman Sachs
12
Goldman Sachs
New York
$20.2M -$7.48M -53,713 -22%
Wells Fargo
13
Wells Fargo
California
$19.8M -$1.32M -9,478 -5%
BIT
14
BlackRock Institutional Trust
California
$19.6M -$32.7K -235 -0.1%
PC
15
Polar Capital
United Kingdom
$15.2M +$4.01M +28,807 +25%
Citadel Advisors
16
Citadel Advisors
Florida
$15.1M +$6.89M +49,481 +53%
BFA
17
BlackRock Fund Advisors
California
$14.6M -$460K -3,300 -2%
FAM
18
Fred Alger Management
New York
$13.7M -$1.16M -8,294 -6%
Millennium Management
19
Millennium Management
New York
$13M +$8.32M +59,697 +95%
CAM
20
Cortina Asset Management
Wisconsin
$12.4M +$303K +2,178 +2%
State Street
21
State Street
Massachusetts
$11.3M -$293K -2,104 -2%
GPP
22
Great Point Partners
Connecticut
$10.3M +$10.9M +77,992 +404%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$9.71M -$43.2K -310 -0.3%
TG
24
TCW Group
California
$9.53M -$229K -1,647 -2%
Bank of Montreal
25
Bank of Montreal
Ontario, Canada
$9.47M +$615K +4,416 +5%

ELGX Hedge Fund Activity: Q3 2014 in Review

120 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q3 2014, worth a combined $701M — down 30% from $1,000M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ELGX positions and 13 closed out — a net gain of 1 holder — while 40 added to existing stakes and 37 trimmed.

The largest buyer was Deerfield Management, adding an estimated $14.2M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $35.1M sold.

  • 120 institutional investors held Endologix Inc (ELGX) as of Q3 2014, up from 119 in Q2 2014.
  • Funds reported $701M of Endologix Inc stock for Q3 2014, down 30% quarter-over-quarter.
  • 14 funds opened new Endologix Inc positions in Q3 2014 and 13 closed out, a net change of +1 holder.
  • The largest Endologix Inc buyer in Q3 2014 was Deerfield Management, an estimated $14.2M added.
  • The largest Endologix Inc seller in Q3 2014 was Massachusetts Financial Services, an estimated $35.1M sold.

Based on aggregated 13F filings for Q3 2014.